POLO Trial - The ASCO Post
Albumin Replacement in Patients with Severe Sepsis or Septic Shock
OncoAlert - Lynparza approved by @US_FDA 🇺🇸for maintenance tx of deleterious germline #BRCA mutated metastatic #PancreaticCancer whose disease not progress on 16 weeks of 1st-line platinum chemo‼️ This based on the POLO
PDF) Colonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer Screening
Diapositiva 1
GI SLIDE DECK 2019 Selected abstracts from: - ppt download
Asco 2019 – Polo reveals an overall survival hole | Evaluate
Acute Lower Gastrointestinal Bleeding
Full article: Emerging drugs for the treatment of ovarian cancer: a focused review of PARP inhibitors
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer | NEJM
NEJM Journal Watch - Home | Facebook
NEJM on Twitter: "The POLO trial evaluated the efficacy of maintenance therapy with olaparib in patients with a germline BRCA mutation and metastatic pancreatic adenocarcinoma that had not progressed during first-line platinum-based
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
GI SLIDE DECK 2019 Selected abstracts from: - ppt download
Upper Gastrointestinal Bleeding Due to a Peptic Ulcer
ex99-1_005.jpg
Update: What is new in targeted therapy for pancreatic cancer? - YouTube
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer | NEJM
Merck and AstraZeneca Present Final Results of Key Secondary Overall Survival Endpoint From Phase 3 PROpel Trial at 2023 American Society of Clinical Oncology Genitourinary Cancers Symposium | Business Wire
NEJM Journal Watch - Postitused | Facebook
NEJM Journal Watch - Postitused | Facebook
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer | NEJM
Novel and Emerging Therapeutic Strategies in the Management of Select Gastrointestinal Cancers Wells A Messersmith, MD Professor and Head, Division of. - ppt download
Cell Death
NEJM Journal Watch - Home | Facebook
Dr. Andrew Hendifar (@DrHendifar) / Twitter
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer | NEJM
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer | NEJM
